CBD is becoming known for helping our overall wellness while supporting some of our physical and cognitive functions.
CBD is short for cannabidiol, a critical Phytocannabinoid found in hemp, known for supporting the body and mind in many ways with no psychoactive effects. CBD comes from the flowers and leaves of the hemp plant, not to be confused with oil from hemp seeds, which doesn’t contain cannabinoids.
Continuous Research
Scientists are eagerly researching the anti-anxiety, anti-psychotic and anti-inflammatory effects of CBD. Some tout it as an over-the-counter solution to aches, pains and insomnia. As the research continues, demand continues to follow.
Validated by the FDA
FDA approval of a hemp-based pharmaceutical drug treatment represents seismic political, legal and economic shifts. Approval will likely lead to more clinical research and further validation of CBD’s therapeutic efficacy.
CBD Legalization
The sale of CBD extracted from the hemp plant—which is our method—is legal in 32 countries in Europe as well as all American states.
The Stillcanna CBD Market Opportunity Across Europe:
-
European market estimated to be C$66.8 Billion by 2020. -
Favourable European governments were one of the worlds first early adapters of CBD. -
Estimated current product demand out strips supply 5 to 1. - Sources: Marijuana Business Daily, Canaccord Genuity Estimate